李源 脑钠肽在心血管疾病临床治疗中的应用价值评价.docxVIP

脑钠肽在心血管疾病临床治疗中的应用价值评价 【摘要】目的 探究脑钠肽在心血管疾病临床治疗中的应用价值。方法 选取2015年3月～2016年3月我院接受治疗的48例心血管疾病患者，按照治疗药物的不同分为治疗组和对照组，各24例。对照组患者采用黄芪甲苷进行治疗，治疗组采用脑钠肽进行治疗，比较两组患者的治疗效果，再次住院率，运动中诱发心绞痛的时间，不同心功能状态下患者血清中脑利钠肽的浓度。结果 治疗组的临床效果优于对照组，再次住院率低于对照组，运动中诱发心绞痛的时间长于对照组，不同心功能状态下患者血清中脑利钠肽的浓度改善情况优于对照组，两组差异显著（P0.05）,有统计学意义。结论 采用脑钠肽心血管疾病患者具有较大的意义，可较好的提高其治疗效果，提升患者满意度，降低患者的再次住院率，延长患者在运动中诱发心绞痛的时间，改善不同心功能状态下患者血清中脑利钠肽的浓度，在临床上为治疗该病患者提供较我突出的依据。 【关键词】脑钠肽；心血管疾病临床；应用价值 心血管疾病是指素所有的循环系统疾病，主要发病在患者的心脏和血管上，该病可 分为急性和慢性，通常情况下该病的发病都与患者的动脉硬化有关，心血管疾病都有着相似的病因和发病机制[1-2]。该病是目前发病率较高的疾病，发病群体大多数是中老年人，但随着快节奏的生活和过重的工作负担，该疾病的发病群体越来越年轻化[3]。现就选取2015年3月～2016年3月我院接受治疗的48例心血管疾病患者进行对照研究，现将研究内容汇报如下。 Application Value of brain natriuretic peptide in clinical treatment of cardiovascular disease Abstract Objective To explore the value of brain natriuretic peptide in clinical treatment of cardiovascular diseases. Methods March 2015 ~ March 2016 in our hospital treated 48 cases of cardiovascular disease, according to different therapeutic agents into the treatment group and the control group, 24 cases each. In the control group were treated with Astragaloside treatment, the treatment group using BNP treatment, the therapeutic effect of two groups were compared, the rate of re-hospitalization, exercise induced angina in time, serum sodium at different cardiac function in the brain Lee the concentration of the peptide. Results The clinical effect of the treatment group than the control group, the readmission rate than the control group, exercise induced angina longer than in the control group, the heart function in patients with different serum concentrations of brain natriuretic peptide in improvement than the control group, the difference was significant (P 0.05), statistically significant. Conclusion of brain natriuretic peptide in patients with cardiovascular disease have greater significance, can better improve the therapeutic effect, enhance patient satisfaction and reduce the rate of re-hospitalization of patients and prolong patients i